Showing results (1441-1450 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical SupportLouis P Garrison, Bernarda Zamora, Meng Li, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice ExperimentDevender S Dhanda, David L Veenstra, Dean A Regier, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Augmenting Cost-Effectiveness Analysis Will Not Improve AffordabilityJohn B Watkins, Emily G TsiaoJournal of Managed Care & Specialty Pharmacy|June 28, 2016
Erectile Dysfunction Medication Use in Veterans Eligible for Medicare Part DSamantha H Spencer, Katie J Suda, Bridget M Smith, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2020
Perceptions and experiences of promotoras and pharmacists in an academic-community partnership providing telephonic MTM services to a Spanish-speaking, rural population: a focus group studyBlanca Guerra, Shannon Vaffis, David R Axon, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2020
Racial disparities in medication use: imperatives for managed care pharmacyStephen J KogutJournal of Managed Care & Specialty Pharmacy|October 12, 2020
Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact modelBrandon J Patterson, William L Herring, Desiree Van Oorschot, et al.Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Pharmacist-managed multistep order transmittal for electronic specialty prescriptions reduces represcribing burden in ambulatory clinics: A retrospective cohort pilot studySammie H Nguyen, Carlina J Grindeland, David D LeedahlJournal of Managed Care & Specialty Pharmacy|June 23, 2022
Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United StatesNina Kim, Jessie Wang, Chakkarin Burudpakdee, et al.Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Patient out-of-pocket and payer costs for pegfilgrastim originator vs biosimilars as primary prophylaxis of febrile neutropenia in the first cycle among a commercially insured populationChing-Yu Wang, Haesuk Park, Coy D Heldermon, et al.Pageof 185